Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTUAL: Irbesartan/HCTZ Titration Strategies in Hypertension
NCT00708344Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 16
01
Overview
Phase 4, randomised, open-label trial of irbesartan and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Sanofi. Primary endpoint: Change in mean Systolic Blood Pressure at 10 weeks. Started Jun 2008; status: completed.
02
Drugs
irbesartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00708344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708344.